| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/14/2023 | BioAtla, Inc. | | Grant | Stock Option (Right to Buy) | 50k | $3.55 | $177.5k | | 06/14/2023 |
| 06/02/2023 | Pasithea Therapeutics Corp. | | Purchase | Common Stock | 30k | $0.43 | $12.9k | | 06/02/2023 |
| 06/01/2023 | 180 Life Sciences Corp. | KBLM | Purchase | Common Stock | 18k | $1.23 | $22.1k | | 06/01/2023 |
| 11/28/2022 | Pasithea Therapeutics Corp. | | Grant | Common Stock | 5k | $0.98 | $4.9k | | 11/28/2022 |
| 11/22/2022 | Pasithea Therapeutics Corp. | | Grant | Common Stock | 5k | $0.99 | $5k | | 11/22/2022 |
| 10/17/2022 | Pasithea Therapeutics Corp. | | Grant | Common Stock | 1000 | $1.14 | $1.1k | | 10/17/2022 |
| 10/17/2022 | Pasithea Therapeutics Corp. | | Grant | Common Stock | 9k | $1.13 | $10.2k | | 10/17/2022 |
| 06/29/2022 | Pasithea Therapeutics Corp. | | Grant | Common Stock | 5k | $1.00 | $5k | | 06/27/2022 |
| 06/28/2022 | Pasithea Therapeutics Corp. | | Grant | Common Stock | 5k | $1.02 | $5.1k | | 06/27/2022 |
| 06/27/2022 | Pasithea Therapeutics Corp. | | Grant | Common Stock | 5k | $1.00 | $5k | | 06/27/2022 |
| 06/23/2022 | Pasithea Therapeutics Corp. | | Grant | Common Stock | 5k | $1.00 | $5k | | 06/23/2022 |
| 06/21/2022 | Pasithea Therapeutics Corp. | | Grant | Common Stock | 652.2k | $0.00 | $0 | | 06/21/2022 |
| 06/16/2022 | BioAtla, Inc. | | Grant | Stock Option (right to buy) | 20k | $2.48 | $49.6k | | 06/16/2022 |
| 12/09/2021 | 180 Life Sciences Corp. | KBLM | Purchase | Common Stock | 5k | $4.27 | $21.4k | | 12/08/2021 |
| 12/08/2021 | 180 Life Sciences Corp. | KBLM | Grant | Stock Option (Right to Buy) | 25k | $3.95 | $98.8k | | 12/08/2021 |
| 11/02/2021 | BioAtla, Inc. | | Sale | Common Stock | 450 | $30.00 | $13.5k | | 11/02/2021 |
| 09/30/2021 | 180 Life Sciences Corp. | KBLM | Grant | Common Stock | 5.2k | $6.00 | $31.3k | | 09/30/2021 |
| 09/15/2021 | BioAtla, Inc. | | Sale | Common Stock | 450 | $36.82 | $16.6k | | 09/15/2021 |
| 08/16/2021 | BioAtla, Inc. | | Sale | Common Stock | 450 | $40.60 | $18.3k | | 08/16/2021 |
| 08/02/2021 | Pasithea Therapeutics Corp. | | Grant | Stock option (to acquire common stock) | 100k | $6.00 | $600k | | 06/21/2022 |
| 07/15/2021 | BioAtla, Inc. | | Sale | Common Stock | 450 | $38.29 | $17.2k | | 07/15/2021 |
| 06/15/2021 | BioAtla, Inc. | | Grant | Stock Option (right to buy) | 12.3k | $39.64 | $487.8k | | 06/14/2021 |
| 06/14/2021 | BioAtla, Inc. | | Other (acquisition) | Common Stock | 5.4k | $0.00 | $0 | | 06/14/2021 |
| 04/07/2021 | 180 Life Sciences Corp. | KBLM | Grant | Common Stock | 22.6k | $6.14 | $138.7k | | 04/07/2021 |
| 06/24/2019 | Atreca, Inc. | BCEL | Conversion | Class A Common Stock | 8.4k | $0.00 | $0 | | 06/24/2019 |
| 06/24/2019 | Atreca, Inc. | BCEL | Conversion | Series A Preferred Stock | 8.4k | $0.00 | $0 | | 06/24/2019 |